K212781 is an FDA 510(k) clearance for the Posterior Fusion Plate/HA Posterior Fusion Plate, Minuteman G3 MIS Fusion Pla.... Classified as Spinous Process Plate (product code PEK), Class II - Special Controls.
Submitted by Spinal Simplicity, LLC (Overland Park, US). The FDA issued a Cleared decision on December 15, 2021 after a review of 105 days - within the typical 510(k) review window.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3050 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Spinal Simplicity, LLC devices
NCT01455805
Completed
Interventional
Industry-sponsored
Minuteman Spinal Fusion Implant Versus Surgical Decompression for Lumbar Spinal Stenosis
Efficacy and Quality of Life Following Treatment of Lumbar Spinal Stenosis, Spondylolisthesis or Degenerative Disc Disease With the Minuteman Interspinous Interlaminar Fusion Implant Versus Surgical Decompression
| Condition studied |
Lumbar Spinal Stenosis; Spondylolisthesis; Degenerative Disc Disease |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Ganesan Baranidharan, Dr |
| Sponsor |
Spinal Simplicity LLC
(industry)
|
Started 2012-06-01
→
Primary completion 2024-03-01
Primary outcome
Change from baseline of clinical efficacy up to 60 months post procedure
Secondary outcome
measures of quality of life
Study completed - no results published.
This trial concluded in 2024 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
View full study on ClinicalTrials.gov